CORRIGENDUM: Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2-Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres

IF 3.4 4区医学 Q2 CHEMISTRY, MEDICINAL ChemMedChem Pub Date : 2024-12-03 DOI:10.1002/cmdc.202400940

引用次数: 0

Abstract

Dr. Philipp Stockmann, Dr. Lydia Kuhnert,* Wencke Leinung, Dr. Tamara Krajnović, Prof. Sanja Mijatović, Prof. Danijela Maksimović-Ivanić, Prof. Walther Honscha, Prof. Evamarie Hey-Hawkins*

Wencke Leinung was mistakenly omitted from the list of authors for this work. This co-author's name now appears correctly, as listed above.

The corrected Acknowledgements now read: “We thank Cathleen Lakoma and Birte K. Scholz for skillful technical assistance. This research was funded by the Ministry of Science, Technological Development and Innovation of the Republic of Serbia (grant number No. 451–03-47/2023-01/200007). Financial support from the Graduate School Leipzig School of Natural Sciences – Building with Molecules and Nano-objects (BuildMoNa) is gratefully acknowledged. Open Access funding enabled and organized by Projekt DEAL.”

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

勘误：碳硼烷作为有效的苯基模拟物：碳硼基喹唑啉及其有机同位体逆转abcg2介导的耐药的比较研究。

Philipp Stockmann博士、Lydia Kuhnert博士、*Wencke Leinung博士、Tamara krajnoviki博士、Sanja mijatoviki教授、Danijela教授Maksimović-Ivanić、Walther Honscha教授、Evamarie Hey-Hawkins*Wencke Leinung教授被错误地遗漏在本研究的作者名单中。这个合著者的名字现在正确地出现了，如上所示。更正后的致谢现在是：“我们感谢凯瑟琳·拉科马和伯特·k·肖尔茨的技术援助。本研究由塞尔维亚共和国科学、技术发展和创新部资助（资助号451 - 03 / 47/2023-01/200007）。来自研究生院莱比锡自然科学学院的财政支持-分子和纳米物体建筑（BuildMoNa）得到感谢。开放获取资金由Projekt DEAL支持和组织。”

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ChemMedChem 医学-药学

CiteScore

6.70

自引率

2.90%

发文量

280

审稿时长

1 months

期刊介绍： Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.